Literature DB >> 31433698

Methamphetamine Use and Cardiovascular Disease.

Christopher G Kevil1,2,3, Nicholas E Goeders4, Matthew D Woolard5, Md Shenuarin Bhuiyan1,2, Paari Dominic6, Gopi K Kolluru1, Connie L Arnold6, James G Traylor1, A Wayne Orr1,2,3.   

Abstract

While the opioid epidemic has garnered significant attention, the use of methamphetamines is growing worldwide independent of wealth or region. Following overdose and accidents, the leading cause of death in methamphetamine users is cardiovascular disease, because of significant effects of methamphetamine on vasoconstriction, pulmonary hypertension, atherosclerotic plaque formation, cardiac arrhythmias, and cardiomyopathy. In this review, we examine the current literature on methamphetamine-induced changes in cardiovascular health, discuss the potential mechanisms regulating these varied effects, and highlight our deficiencies in understanding how to treat methamphetamine-associated cardiovascular dysfunction.

Entities:  

Keywords:  atherosclerosis; cardiac arrhythmias; cardiomyopathy; methamphetamine; pulmonary hypertension; substance-related disorders; vasoconstriction

Mesh:

Substances:

Year:  2019        PMID: 31433698      PMCID: PMC6709697          DOI: 10.1161/ATVBAHA.119.312461

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  63 in total

Review 1.  Innate and adaptive immunity in the pathogenesis of atherosclerosis.

Authors:  Göran K Hansson; Peter Libby; Uwe Schönbeck; Zhong-Qun Yan
Journal:  Circ Res       Date:  2002-08-23       Impact factor: 17.367

Review 2.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

3.  Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles.

Authors:  S B Karch; B G Stephens; C H Ho
Journal:  J Forensic Sci       Date:  1999-03       Impact factor: 1.832

4.  Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells.

Authors:  Y W Lee; B Hennig; J Yao; M Toborek
Journal:  J Neurosci Res       Date:  2001-11-15       Impact factor: 4.164

5.  Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies.

Authors:  Emily C Nguyen; Kari A McCracken; Yun Liu; Buddy Pouw; Rae R Matsumoto
Journal:  Neuropharmacology       Date:  2005-10       Impact factor: 5.250

6.  Direct effects of methamphetamine on hypertrophy and microtubules in cultured adult rat ventricular myocytes.

Authors:  Y Maeno; M Iwasa; H Inoue; H Koyama; R Matoba; M Nagao
Journal:  Forensic Sci Int       Date:  2000-09-11       Impact factor: 2.395

Review 7.  Implications of chronic methamphetamine use: a literature review.

Authors:  Charles W Meredith; Craig Jaffe; Kathleen Ang-Lee; Andrew J Saxon
Journal:  Harv Rev Psychiatry       Date:  2005 May-Jun       Impact factor: 3.732

8.  Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?

Authors:  Kelly M Chin; Richard N Channick; Lewis J Rubin
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

9.  Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?

Authors:  Mevan Wijetunga; Todd Seto; Joseph Lindsay; Irwin Schatz
Journal:  J Toxicol Clin Toxicol       Date:  2003

10.  Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.

Authors:  Dawn D Han; Howard H Gu
Journal:  BMC Pharmacol       Date:  2006-03-03
View more
  38 in total

1.  Prenatal exposure to methamphetamine in rats induces endothelial dysfunction in male but not female adult offspring.

Authors:  Allison M Harrison; Manoranjan S D'Souza; Sarah L Seeley; Sophocles Chrissobolis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-07       Impact factor: 3.000

2.  The emergence of cardiac changes following the self-administration of methamphetamine.

Authors:  Jessica L Freeling; Lisa M McFadden
Journal:  Drug Alcohol Depend       Date:  2020-04-23       Impact factor: 4.492

Review 3.  Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Authors:  Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-28

4.  Frequency of reported methamphetamine use linked to prevalence of clinical conditions, sexual risk behaviors, and social adversity in diverse men who have sex with men in Los Angeles.

Authors:  Steve Shoptaw; Michael J Li; Marjan Javanbakht; Amy Ragsdale; David Goodman-Meza; Pamina M Gorbach
Journal:  Drug Alcohol Depend       Date:  2022-01-19       Impact factor: 4.492

5.  Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities.

Authors:  Amber N Edinoff; Sarah E Kaufman; Keionne M Green; Daniel A Provenzano; Jesse Lawson; Elyse M Cornett; Kevin S Murnane; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-09-15

6.  A Chronic Condition Disguised as an Acute Event: the Case for Re-thinking Stimulant Overdose Death.

Authors:  Elise D Riley; Priscilla Y Hsue; Phillip O Coffin
Journal:  J Gen Intern Med       Date:  2022-06-17       Impact factor: 6.473

7.  Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography.

Authors:  Kyoji Okita; Toshihiko Matsumoto; Daisuke Funada; Maki Murakami; Koichi Kato; Yoko Shigemoto; Noriko Sato; Hiroshi Matsuda
Journal:  Front Pharmacol       Date:  2022-05-11       Impact factor: 5.988

8.  Retinal hypoxia and angiogenesis with methamphetamine.

Authors:  Minsup Lee; Wendy Leskova; Randa S Eshaq; Norman R Harris
Journal:  Exp Eye Res       Date:  2021-03-15       Impact factor: 3.467

9.  Potential Role of Serum S-100β Protein as a Predictor of Cardiotoxicity and Clinical Poor Outcome in Acute Amphetamine Intoxication.

Authors:  Asmaa F Sharif; Eman Elsheikh; Abdullah Z Al-Asmari; Dina El Gameel
Journal:  Cardiovasc Toxicol       Date:  2021-01-09       Impact factor: 3.231

Review 10.  Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Neurosci Biobehav Rev       Date:  2022-04-20       Impact factor: 9.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.